These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

344 related items for PubMed ID: 19618456

  • 1. Is pegfilgrastim safe and effective in congenital neutropenia? An analysis of the French Severe Chronic Neutropenia registry.
    Beaupain B, Leblanc T, Reman O, Hermine O, Vannier JP, Suarez F, Lutz P, Bordigoni P, Jourdain A, Schoenvald M, Ouachee M, François S, Kohser F, Jardin F, Devouassoux G, Bertrand Y, Nove-Josserand R, Donadieu J, French SCN Registry, Service d'Hémato Oncologie Pédiatrique.
    Pediatr Blood Cancer; 2009 Dec; 53(6):1068-73. PubMed ID: 19618456
    [Abstract] [Full Text] [Related]

  • 2. Safety and efficacy of pegfilgrastim in children with cancer receiving myelosuppressive chemotherapy.
    André N, Kababri ME, Bertrand P, Rome A, Coze C, Gentet JC, Bernard JL.
    Anticancer Drugs; 2007 Mar; 18(3):277-81. PubMed ID: 17264759
    [Abstract] [Full Text] [Related]

  • 3. Retrospective comparison of neutropenia in children with Ewing sarcoma treated with chemotherapy and granulocyte colony-stimulating factor (G-CSF) or pegylated G-CSF.
    Milano-Bausset E, Gaudart J, Rome A, Coze C, Gentet JC, Padovani L, Lacarelle B, André N.
    Clin Ther; 2009 Mar; 31 Pt 2():2388-95. PubMed ID: 20110048
    [Abstract] [Full Text] [Related]

  • 4. Comparison of pegfilgrastim with filgrastim on febrile neutropenia, grade IV neutropenia and bone pain: a meta-analysis of randomized controlled trials.
    Pinto L, Liu Z, Doan Q, Bernal M, Dubois R, Lyman G.
    Curr Med Res Opin; 2007 Sep; 23(9):2283-95. PubMed ID: 17697451
    [Abstract] [Full Text] [Related]

  • 5. A pharmacokinetic and dose escalation study of pegfilgrastim (KRN125) in lung cancer patients with chemotherapy-induced neutropenia.
    Yamamoto N, Sekine I, Nakagawa K, Takada M, Fukuoka M, Tanigawara Y, Saijo N.
    Jpn J Clin Oncol; 2009 Jul; 39(7):425-30. PubMed ID: 19395467
    [Abstract] [Full Text] [Related]

  • 6. Pegfilgrastim in children with severe congenital neutropenia.
    Fioredda F, Calvillo M, Lanciotti M, Lanza T, Giunti L, Castagnola E, Lorenzi I, Tonelli R, Ghezzi P, Dufour C.
    Pediatr Blood Cancer; 2010 Mar; 54(3):465-7. PubMed ID: 19927291
    [Abstract] [Full Text] [Related]

  • 7. Sustained G-CSF plasma levels following administration of pegfilgrastim fasten neutrophil reconstitution after high-dose chemotherapy and autologous blood stem cell transplantation in patients with multiple myeloma.
    Fenk R, Hieronimus N, Steidl U, Bruns I, Graef T, Zohren F, Ruf L, Haas R, Kobbe G.
    Exp Hematol; 2006 Oct; 34(10):1296-302. PubMed ID: 16982322
    [Abstract] [Full Text] [Related]

  • 8. Pegfilgrastim administered on the same day with dose-dense adjuvant chemotherapy for breast cancer is associated with a higher incidence of febrile neutropenia as compared to conventional growth factor support: matched case-control study of the Hellenic Cooperative Oncology Group.
    Skarlos DV, Timotheadou E, Galani E, Samantas E, Grimani I, Lianos E, Aravantinos G, Xanthakis I, Pentheroudakis G, Pectasides D, Fountzilas G.
    Oncology; 2009 Oct; 77(2):107-12. PubMed ID: 19622901
    [Abstract] [Full Text] [Related]

  • 9. Safety and efficacy of once-per-cycle pegfilgrastim in support of ABVD chemotherapy in patients with Hodgkin lymphoma.
    Younes A, Fayad L, Romaguera J, Pro B, Goy A, Wang M.
    Eur J Cancer; 2006 Nov; 42(17):2976-81. PubMed ID: 17008093
    [Abstract] [Full Text] [Related]

  • 10. Risk of hospitalization for neutropenic complications of chemotherapy in patients with primary solid tumors receiving pegfilgrastim or filgrastim prophylaxis: a retrospective cohort study.
    Weycker D, Malin J, Kim J, Barron R, Edelsberg J, Kartashov A, Oster G.
    Clin Ther; 2009 May; 31(5):1069-81. PubMed ID: 19539108
    [Abstract] [Full Text] [Related]

  • 11. Peripheral blood stem cell mobilization with pegfilgrastim compared to filgrastim in children and young adults with malignancies.
    Fritsch P, Schwinger W, Schwantzer G, Lackner H, Sovinz P, Wendelin G, Benesch M, Sipurzynski S, Urban C.
    Pediatr Blood Cancer; 2010 Jan; 54(1):134-7. PubMed ID: 19785023
    [Abstract] [Full Text] [Related]

  • 12. Severe chronic neutropenia: treatment and follow-up of patients in the Severe Chronic Neutropenia International Registry.
    Dale DC, Cottle TE, Fier CJ, Bolyard AA, Bonilla MA, Boxer LA, Cham B, Freedman MH, Kannourakis G, Kinsey SE, Davis R, Scarlata D, Schwinzer B, Zeidler C, Welte K.
    Am J Hematol; 2003 Feb; 72(2):82-93. PubMed ID: 12555210
    [Abstract] [Full Text] [Related]

  • 13. A combined analysis of two pivotal randomized trials of a single dose of pegfilgrastim per chemotherapy cycle and daily Filgrastim in patients with stage II-IV breast cancer.
    Siena S, Piccart MJ, Holmes FA, Glaspy J, Hackett J, Renwick JJ.
    Oncol Rep; 2003 Feb; 10(3):715-24. PubMed ID: 12684649
    [Abstract] [Full Text] [Related]

  • 14. Pegfilgrastim after high-dose chemotherapy and autologous peripheral blood stem cell transplant: phase II study.
    Jagasia MH, Greer JP, Morgan DS, Mineishi S, Kassim AA, Ruffner KL, Chen H, Schuening FG.
    Bone Marrow Transplant; 2005 Jun; 35(12):1165-9. PubMed ID: 15880129
    [Abstract] [Full Text] [Related]

  • 15. Granulocytic growth factors and cancer-related neutropenia: limited effects.
    Prescrire Int; 2006 Oct; 15(85):189-91. PubMed ID: 17128529
    [Abstract] [Full Text] [Related]

  • 16. Elderly cancer patients receiving chemotherapy benefit from first-cycle pegfilgrastim.
    Balducci L, Al-Halawani H, Charu V, Tam J, Shahin S, Dreiling L, Ershler WB.
    Oncologist; 2007 Dec; 12(12):1416-24. PubMed ID: 18165618
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Retrospective comparison of the effects of filgrastim and pegfilgrastim on the pace of engraftment in auto-SCT patients.
    Mathew S, Adel N, Rice RD, Panageas K, Duck ET, Comenzo RL, Kewalramani T, Nimer SD.
    Bone Marrow Transplant; 2010 Oct; 45(10):1522-7. PubMed ID: 20062102
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.